Clinical Trials Logo

Clinical Trial Summary

There is evidence that controlling total amount of carbohydrates is a strategy for controlling glucose levels in diabetes mellitus. There is not major evidence that any given macronutrient percentage may be recommended to treat a woman with Gestational Diabetes Mellitus (GDM). In the investigators' country, insulin is the second-line treatment once medical nutrition therapy (MNT) has failed to control glucose levels during pregnancy. Insulin treatment is more expensive and not as well accepted as MNT. The investigators have designed a randomized-controlled trial to assess whether a diet with 40% total calories from carbohydrates may reduce the need of insulin treatment in women with gestational diabetes, without having unfavourable pregnancy outcomes, in comparison with a diet with 55% total calories from carbohydrates.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00911404
Study type Interventional
Source Hospital Arnau de Vilanova
Contact
Status Completed
Phase N/A
Start date January 2009
Completion date July 2012

See also
  Status Clinical Trial Phase
Recruiting NCT03062475 - Lifestyle Intervention to Prevent the Recurrence of Gestational Diabetes Mellitus N/A
Recruiting NCT05179798 - The Study of Recommendation System DiaCompanion for Women With Gestational Diabetes Mellitus N/A
Not yet recruiting NCT03700034 - mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal N/A
Active, not recruiting NCT02025673 - Study of Betatrophin Levels in Patients With Type 2 Diabetes and Gestational Diabetes and Healthy Subjects N/A
Active, not recruiting NCT01554358 - Tianjin Gestational Diabetes Prevention Program (TGDPP) N/A